Article Data

  • Views 296
  • Dowloads 61

Original Research

Open Access

Temporomandibular Disorder–Type Pain and Migraine Headache in Women: A Preliminary Twin Study

  • Octavia Plesh1,*,
  • Carolyn Noonan2
  • Dedra S. Buchwald2
  • Jack Goldberg3
  • Niloo Afari4

1Department of Preventive and Restorative Dental Sciences, University of California, San Francisco, San Francisco, California, USA

2Department of Medicine, University of Washington, Seattle, Washington, USA

3Department of Epidemiology, University of Washington, Seattle, Washington, USA

4Department of Psychiatry, University of California, San Diego and VA Center of Excellence for Stress and Mental Health, San Diego, California, USA

DOI: 10.11607/jofph.2691 Vol.26,Issue 2,June 2012 pp.91-98

Published: 30 June 2012

*Corresponding Author(s): Octavia Plesh E-mail: octavia.plesh@ucsf.edu

Abstract

Aims: To determine whether shared genetic influences are responsible for the association between pain from temporomandibular disorders (TMD) and migraine headache. Methods: Data were obtained from 1,236 monozygotic and 570 dizygotic female twin pairs from the University of Washington Twin Registry. TMD pain was assessed with a question about persistent or recurrent pain in the jaw, temple, in front of the ear, or in the ear. The presence of migraine headache was determined by self-report of doctor-diagnosed migraine. Univariate and bivariate structural equation models estimated the components of variance attributable to genetic and environmental influences. Results: The best fitting univariate models indicated that additive genetic effects contributed 27% of the variance in TMD pain (95% confidence interval = 15% to 38%) and 49% of the variance in migraine headache (95% confidence interval = 40% to 57%). The best-fitting bivariate model revealed that 12% of the genetic component of TMD pain is shared with migraine headache. Conclusion: These preliminary findings suggest that the association between TMD pain and migraine headache in women may be partially due to a modest shared genetic risk for both conditions. Future studies can focus on replicating these findings with symptom- and diagnosis-based instruments.


Cite and Share

Octavia Plesh,Carolyn Noonan,Dedra S. Buchwald,Jack Goldberg,Niloo Afari. Temporomandibular Disorder–Type Pain and Migraine Headache in Women: A Preliminary Twin Study. Journal of Oral & Facial Pain and Headache. 2012. 26(2);91-98.

References

1. LeResche L, Drangsholt M. Epidemiology of orofacial pain. In: Sessle B, Levigne GP, Lund JP, Dubner R (eds). Orofacial Pain, ed 2. Chicago: Quintessence; 2008:13–18.

2. Drangsholt M, LeResche L. Temporomandibular disorder pain. In: Crombie I, Croft PR, Liton SJ (eds). Epidemiology of Pain. Seattle: IASP, 1999:203–233.

3. Bevilaqua-Grossi D, Lipton RB, Napchan U, Grosberg B, Ashina S, Bigal ME. Temporomandibular disorders and cutaneous allodynia are associated in individuals with migraine. Cephalalgia 2010;30:425–432.

4. Goncalves DA, Bigal ME, Jales LC, Camparis CM, Speciali JG. Headache and symptoms of temporomandibular disorder: An epidemiological study. Headache 2009;50:231–241.

5. Goncalves DA, Camparis CM, Speciali JG, Franco AL, Bigal ME. Temporomandibular disorders are differentially associated with headache diagnoses. A controled study. Clin J Pain 2011;27:611–615.

6. Goncalves DA, Dal Fabbro AL, Campos JA, Bigal ME, Speciali JG. Symptoms of temporomandibular disorders in the population: An epidemiological study. J Orofac Pain 2010;24:270–278.

7. Munakata J, Hazard E, Serrano D, et al. Economic burden of transformed migraine: Results from the American migraine prevalence and prevention (AMPP) study. Headache 2009;49:498–508.

8. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343–349.

9. LeResche L. Epidemiology of temporomandibular disorders: Implications for the investigation of etiologic factors. Crit Rev Oral Biol Med 1997;8:291–305.

10. Mulder EJ, Van Baal C, Gaist D, et al. Genetic and environmental influences on migraine: A twin study across six countries. Twin Res 2003;6:422–431.

11. Graff-Radford SB. Temporomandibular disorders and headache. Dent Clin North Am 2007;51:129–144.

12. Svensson P. Muscle pain in the head: Overlap between temporomandibular disorders and tension-type headaches. Curr Opin Neurol 2007;20:320–325.

13. Ayesh EE, Jensen TS, Svensson P. Hypersensitivity to mechanical and intra-articular electrical stimuli in persons with painful temporomandibular joints. J Dent Res 2007;86:1187–1192.

14. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine: Evidence for peripheral sensitisation. Lancet Neurol 2009;8:679–690.

15. Maixner W, Fillingim R, Booker D, Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 1995;63:341–351.

16. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol 2008;63:148–158.

17. Diatchenko L, Nackley AG, Tchivileva IE, Shabalina SA, Maixner W. Genetic architecture of human pain perception. Trends Genet 2007;23:605–613.

18. Lacroix-Fralish ML, Mogil JS. Progress in genetic studies of pain and analgesia. Annu Rev Pharmacol Toxicol. 2009;49:97–121.

19. Stewart WF, Bigal ME, Kolodner K, Dowson A, Liberman JN, Lipton RB. Familial risk of migraine: Variation by proband age at onset and headache severity. Neurology 2006;66:344–348.

20. Matsuka Y, Nagamatsu C, Itoh S, et al. Comparison of inter-twin concordance in symptoms of temporomandibular disorders: A preliminary investigation in an adolescent twin population. Cranio 2007;25:23–29.

21. Makchalowicz BS, Pihlstrom BL, Hodges JS, Bouchard TJ Jr. No heritability of temporomandibular joint signs and symptoms. J Dent Res 2000;79:1573–1578.

22. Plesh O, Afari N, Noonan C, Arguelles LM, Goldberg J, Buchwald D. TMJMD-type pain: A twin study. J Dent Res 2007;86(special issue A):263.

23. Afari N, Noonan C, Goldberg J, et al. University of Washington twin registry: Construction and characteristics of a community-based twin registry. Twin Res Hum Genet 2006;9:1023–1029.

24. Eisen S, Neuman R, Goldberg J, Rice J, True W. Determining zygosity in the Vietnam era twin registry: An approach using questionnaires. Clin Genet 1989;35:423–432.

25. Magnus P, Berg K, Nance WE. Predicting zygosity in Norwegian twin pairs born 1915–1960. Clin Genet 1983;24:103–112.

26. Reed T, Plassman BL, Tanner CM, Dick DM, Rinehart SA, Nichols WC. Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC twin reg- istry 40 years later. Twin Res Hum Genet 2005;8:362–367.

27. Torgersen S. The determination of twin zygosity by means of a mailed questionnaire. Acta Genet Med Gemellol (Roma) 1979;28:225–236.

28. Von Korff M, Dworkin SF, Le Resche L, Kruger A. An epidemiologic comparison of pain complaints. Pain 1988;32:173–183.

29. Plesh O, Sinisi SE, Crawford PB, Gansky SA. Diagnoses based on the research diagnostic criteria for temporomandibular disorders in a biracial population of young women. J Orofac Pain 2005;19:65–75.

30. Drangsholt M, Mancl LA, LeResche L. Relationship of self-report of temporomandibular pain with RDC/TMD diagnostic examination in adolescents. J Dent Res 2003;82(special issue):B178.

31. Neale M, Cardon L. Methodology for the Study of Twins and Families. Dordrecht, The Netherlands: Kluwer Academ- ic, 1992.

32. Akaike H. Factor analysis and AIC. Psychometrika. 1987;52:327–332.

33. Oakley M, Vieira AR. The many faces of the genetics contribution to temporomandibular joint disorder. Orthod Craniofac Res 2008;11:125–135.

34. Stewart WF, Staffa J, Lipton RB, Ottman R. Familial risk of migraine: A population-based study. Ann Neurol 1997;41:166–172.

35. Russell MB, Iselius L, Olesen J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 1996;16:305–309.

36. Merikangas KR, Risch NJ, Merikangas JR, Weissman MM, Kidd KK. Migraine and depression: Association and familial transmission. J Psychiatr Res 1988;22:119–129.

37. Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB. The relative role of genetic and environmental factors in migraine without aura. Neurology 1999;53:995–999.

38. Larsson B, Bille B, Pedersen NL. Genetic influence in headaches: A Swedish twin study. Headache 1995;35:513–519.

39. Diatchenko L, Anderson AD, Slade GD, et al. Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet 2006;141B:449–462.

40. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005;14:135–143.

41. Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain 2007;128:199–208.

42. Ojima K, Watanabe N, Narita N, Narita M. Temporomandibular disorder is associated with a serotonin transporter gene polymorphism in the Japanese population. Biopsychosoc Med 2007;1:3.

43. Karwautz AF, Campos de Sousa S, Wober C, et al. Family- based analysis of serotonin transporter gene polymor- phisms in migraine with and without aura. Cephalalgia 2007;27:773–780.

44. Wieser T, Dresler K, Evers S, et al. No influence of 5-HTTLPR gene polymorphism on migraine symptomatology, comorbid depression, and chronification. Headache 2010;50:420–430.

45. Bayerer B, Engelbergs J, Savidou I, et al. Single nucleotide polymorphisms of the serotonin transporter gene in migraine: An association study. Headache 2010;50:319–322.

46. Marino E, Fanny B, Lorenzi C, et al. Genetic bases of comorbidity between mood disorders and migraine: Possible role of serotonin transporter gene. Neurol Sci 2010;31:387–391.

47. Schurks M, Rist PM, Kurth T. STin2 VNTR polymorphism in the serotonin transporter gene and migraine: Pooled and meta-analyses. J Headache Pain 2010;11:317–326.

48. MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol 2004;3:354–361.

49. Colson N, Fernandez F, Griffiths L. Genetics of menstrual migraine: The molecular evidence. Curr Pain Headache Rep 2010;14:389–395.

50. Oterino A, Toriello M, Cayon A, et al. Multilocus analyses reveal involvement of the ESR1, ESR2, and FSHR genes in migraine. Headache 2008;48:1438–1450.

51. Plesh O, Adams S, Gansky SA. Temporomandibular joint and muscle disorder-type pain and comorbid pains in a national US sample. J Orofac Pain 2011;25:190–198.

52. Scher AI, Stewart WF, Buse D, Krantz DS, Lipton RB. Major life changes before and after the onset of chronic daily headache: A population-based study. Cephalalgia 2008;28:868–876.

53. Slade GD, Diatchenko L, Bhalang K, et al. Influence of psychological factors on risk of temporomandibular disorders. J Dent Res 2007;86:1120–1125.

54. Anderson GC, John MT, Ohrbach R, Nixdorf DR, Schiffman EL. Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain. Pain 2011;152:765–771.


Abstracted / indexed in

Science Citation Index (SCI)

Science Citation Index Expanded (SCIE)

BIOSIS Previews

Scopus

Cumulative Index to Nursing and Allied Health Literature (CINAHL)

Submission Turnaround Time

Conferences

Top